{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-239535","form_type":"8-K","ticker":"VKTX","cik":"0001607678","company_name":"Viking Therapeutics, Inc.","filed_at":"2026-05-26T20:48:01+00:00","discovered_at":"2026-05-26T20:48:54.654168+00:00","generated_at":"2026-05-26T20:52:26.036947+00:00","sec_items":["5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"confidence":"high","headline":"Viking Therapeutics annual meeting elects two Class II directors, ratifies auditor","bullets":["J. Matthew Singleton elected with 28.6M votes for; S. Kathryn Rouan with 22.0M for.","Ratification of CBIZ CPAs as independent auditor for FY 2026 approved (78.4M for, 1.2M against).","Advisory vote on named executive officer compensation passed (30.0M for, 12.8M against).","Quorum achieved with 80.1M shares (69.1% of outstanding) represented at the meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-239535","json":"https://secwatch.observer/filing/0001193125-26-239535.json","markdown":"https://secwatch.observer/filing/0001193125-26-239535.md","text":"https://secwatch.observer/filing/0001193125-26-239535.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1607678/000119312526239535/0001193125-26-239535-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1607678/000119312526239535/vktx-20260519.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T20:52:26.036947+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}